Ep108: Praveen Tipirneni on Targeting Integrins With Small Molecules
The Long Run with Luke Timmerman - Podcast készítő Timmerman Report
Praveen Tipirneni, CEO of Morphic Therapeutic, on targeting integrins with small molecules.
The Long Run with Luke Timmerman - Podcast készítő Timmerman Report
Praveen Tipirneni, CEO of Morphic Therapeutic, on targeting integrins with small molecules.